Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Vatter

Showing results (281-290 of 311) with videos related to

Pageof 32
Sort By:
Scientific Data|July 20, 2023
An open presurgery MRI dataset of people with epilepsy and focal cortical dysplasia type IIFabiane Schuch, Lennart Walger, Matthias Schmitz, et al.
International Journal of Cancer|October 28, 2020
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trialTheophilos Tzaridis, Niklas Schäfer, Johannes Weller, et al.
Clinical and Translational Radiation Oncology|August 18, 2025
Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort studyCas S Dejonckheere, Thomas Zeyen, Cathrina Duffy, et al.
Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 10, 2020
DNA Methylation-Mediated Modulation of Endocytosis as Potential Mechanism for Synaptic Function Regulation in Murine Inhibitory Cortical InterneuronsDaniel Pensold, Julia Reichard, Karen M J Van Loo, et al.
Journal of Cancer Research and Clinical Oncology|May 30, 2018
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trialChristina Schaub, Sied Kebir, Nina Junold, et al.
Ebiomedicine|November 12, 2025
Blood-brain barrier opening as a predictor of epilepsy and mortality after subarachnoid haemorrhageJens P Dreier, Svetlana Lublinsky, Viktor Horst, et al.
Cancers|July 29, 2023
Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain MetastasesChristian D Diehl, Frank A Giordano, Anca-L Grosu, et al.
Journal of Neuro-Oncology|October 9, 2023
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomesCas S Dejonckheere, Julian P Layer, Motaz Hamed, et al.
BMC Cancer|May 11, 2021
No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in GermanyRoman Rüdiger, Franziska Geiser, Manuel Ritter, et al.
Pageof 32

Showing results (281-290 of 311) with videos related to

Sort By:
Pageof 32
Scientific Data|July 20, 2023
An open presurgery MRI dataset of people with epilepsy and focal cortical dysplasia type IIFabiane Schuch, Lennart Walger, Matthias Schmitz, et al.
International Journal of Cancer|October 28, 2020
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trialTheophilos Tzaridis, Niklas Schäfer, Johannes Weller, et al.
Clinical and Translational Radiation Oncology|August 18, 2025
Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort studyCas S Dejonckheere, Thomas Zeyen, Cathrina Duffy, et al.
Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 10, 2020
DNA Methylation-Mediated Modulation of Endocytosis as Potential Mechanism for Synaptic Function Regulation in Murine Inhibitory Cortical InterneuronsDaniel Pensold, Julia Reichard, Karen M J Van Loo, et al.
Journal of Cancer Research and Clinical Oncology|May 30, 2018
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trialChristina Schaub, Sied Kebir, Nina Junold, et al.
Ebiomedicine|November 12, 2025
Blood-brain barrier opening as a predictor of epilepsy and mortality after subarachnoid haemorrhageJens P Dreier, Svetlana Lublinsky, Viktor Horst, et al.
Cancers|July 29, 2023
Opportunities and Alternatives of Modern Radiation Oncology and Surgery for the Management of Resectable Brain MetastasesChristian D Diehl, Frank A Giordano, Anca-L Grosu, et al.
Journal of Neuro-Oncology|October 9, 2023
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomesCas S Dejonckheere, Julian P Layer, Motaz Hamed, et al.
BMC Cancer|May 11, 2021
No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in GermanyRoman Rüdiger, Franziska Geiser, Manuel Ritter, et al.
Pageof 32